News
A balloon pump for the heart is also called an intra-aortic balloon pump (IABP). ... You can learn more about how we ensure our content is accurate and current by reading our editorial policy.
Researchers report that the elective use of IABP during PCI was associated with a 34% reduction in the risk of death after a median follow-up of 51 months. They were cautious in interpreting the ...
Adv Neonatal Care. 2005;5(5):252-261. In another study of VLBW neonates (<1500 g) over a wide range of BP values, there was a good correlation of NIBP to IABP. [34] When only comparisons from the ...
To evaluate the accuracy of blood pressure (BP) measured non-invasively (NIBP) compared with invasive arterial BP (IABP) measured by umbilical arterial catheter in neonates undergoing therapeutic ...
A balloon pump inserted in the aorta is currently the most widely used support device in the treatment of cardiogenic shock and, since its introduction in 1968, has been used in several million ...
IV iron supplementation in HFrEF patients showed a 21% reduction in cardiovascular death or first HF hospitalization, despite not meeting primary endpoints. Intra-aortic balloon pump did not ...
The overall rate of all-cause mortality was 33%; 42 of 151 patients receiving elective IABP (28%) died, as did 58 of 150 patients receiving no IABP (39%). At 5 years, Kaplan-Meier estimates indicate ...
After adjustment, mean hospital length of stay was 3.4 days with Impella and 4.8 days with IABP. Mean hospital costs were 37% higher with the PVAD ($48,784 vs $35,655 with IABP). Among surviving ...
The addition to the IABP family supports uncompromised cardiac support for patients during transportWAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading ...
The Arrow ® AC3 Optimus™ IABP has a third-generation AutoPilot ® Mode, which uses proprietary algorithms to address key clinical challenges and to simplify the delivery of IABP therapy. 3 In ...
WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results